Adolescent immunizations: A position paper of the Society for Adolescent Medicine

Journal of Adolescent Health

Volumn 38, Issue 3, 2006, Pages 321-327

  Middleman, Amy B ^a   Rosenthal, Susan L ^b   Rickert, Vaughn I ^c   Neinstein, Lawrence ^d   Fishbein, Daniel B ^e   D'Angelo, Lawrence ^f  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; MENINGOCOCCUS VACCINE; PERTUSSIS VACCINE; POLYSACCHARIDE VACCINE; WART VIRUS VACCINE;

ADOLESCENCE; ARTICLE; CLINICAL TRIAL; COST CONTROL; HEALTH PROMOTION; HEALTH SERVICE; HUMAN; IMMUNIZATION; MEDICAL SOCIETY; MENINGITIS; MENINGOCOCCEMIA; MENINGOCOCCOSIS; PERTUSSIS; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; SEXUALLY TRANSMITTED DISEASE; VACCINATION; VIRUS INFECTION; WART VIRUS; WELLBEING;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; ADOLESCENT MEDICINE; CHILD; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; MALE; MENINGOCOCCAL VACCINES; OFFICE VISITS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PERTUSSIS VACCINE; SOCIETIES, MEDICAL; VIRAL VACCINES;

EID: 32644482373     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2006.01.002     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention Achievements in public health hepatitis B vaccination-United States, 1982-2002 MMWR 2002 549 552 563.
2. J. Klein, K. Wilson, M. McNulty Access to medical care for adolescents results from the 1997 Commonwealth Fund Survey of the Health of Adolescent Girls J Adolesc Health 25 1999 120 130
3. Centers for Disease Control and Prevention. Health, United States, 2004 [cited 2006 Jan 4]. Available from: http://www.cdc.gov/nchs/data/hus/hus04.pdf
4. S. Rosenthal, R. Kottenhahn, F. Biro, P. Succop Hepatitis B vaccine acceptance among adolescents and their parents J Adolesc Health 17 1995 248 254
5. S. Rosenthal, L. Stanberry Parental acceptability of vaccines for sexually transmitted infections Arch Pediatr Adolesc Med 159 2005 190 191
6. N. Oster, C. McPhillips-Tangum, F. Averhoff, K. Howell Barriers to adolescent immunization a survey of family physicians and pediatricians J Am Board Fam Pract 18 2005 13 19
7. G. Zimet, R. Mays, L. Sturm Parental attitudes about sexually transmitted infection vaccination for their adolescent children Arch Pediatr Adolesc Med 159 2005 132 137
8. K. Davis, E. Dickman, D. Ferris, J. Dias Human papillomavirus vaccine acceptablity among parents of 10- to 15-year- old adolescents J Low Genit Tract Dis 8 2004 188 194
9. G. Zimet, S. Perkins, L. Sturm Predictors of STI vaccine acceptablity among parents and their adolescent children J Adolesc Health 37 2005 179 186
10. E. Olshen, E. Woods, S. Austin Parental acceptance of the human papillomavirus vaccine J Adolesc Health 37 2005 248 251
11. N. Halsey, L. Moulton, J. O'Donovan Hepatitis B vaccine administered to children and adolescents at yearly intervals Pediatrics 103 1999 1243 1247
12. F. Averhoff, L. Linton, K. Peddecord A middle school immunization law rapidly and substantially increases immunization coverage among adolescents Am J Public Health 94 2004 978 984
13. R. Jacobs, A. Meyerhoff Effect of middle school entry requirements on hepatitis B vaccination coverage J Adolesc Health 34 2004 420 423
14. S. Humiston, S. Rosenthal Challenges to vaccinating adolescents vaccine implementation issues Pediatr Infect Dis J 24 6 2005 S134 S140
15. J. Callahan, D. Reed, V. Meguid Utility of an immunization registry in a pediatric emergency department Pediatr Emerg Care 20 2004 297 301
16. N.E. Rosenstein, D. Stephens, L. Lefkowitz The changing epidemiology of meningococcal disease in the United States, 1992-1996 J Infect Dis 180 1999 1894 1901
17. O. Bilukha, N. Rosenstein Prevention and Control of Meningococcal Disease 2005 Centers for Disease Control Atlanta, GA
18. L.H. Harrison, M.A. Pass, A.B.P. Mendelsohn Invasive meningococcal disease in adolescents and young adults JAMA 286 2001 694 699
19. G. Ada, D. Isaacs Carbohydrate-protein conjugate vaccines Clin Microbiol Infect 9 2003 79 85
20. Centers for Disease Control and Prevention Pertussis - United States, 1997-2000 MMRW 51 2002 73 76
21. Centers for Disease Control and Prevention Pertussis surveillance report MMWR 54 2005 770
22. T. Tan, E. Trindade, D. Skowronski Epidemiology of pertussis Pediatr Infect Dis J 24 5 2005 S10 S18
23. P. Strebel, J. Nordin, K.M. Edwards Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996 J Infect Dis 183 2001 1353 1359
24. Public Health Agency of Canada Canada Communicable Disease Report. Enhanced surveillance for vaccine-associated adverse events: dTap catch-up of high school students in Yukon Vol. 31 2005 Public Health Agency of Canada
25. C. Shepard, I. Ortega-Sanchez, D. Scott Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States Pediatrics 115 2005 1220 1232
26. J. Hay, J. Ward Economic considerations for pertussis booster vaccination in adolescents Pediatr Infect Dis J 24 6 2005 S127 S133
27. K. Purdy, J. Hay, M. Botteman, J.I. Ward Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults a cost-benefit analysis Clin Infect Dis 39 2004 20 28
28. G. Lee, C. Lebaron, T. Murphy Pertussis in adolescents and adults should we vaccinate? Pediatrics 115 2005 1675 1684
29. Centers for Disease Control and Prevention. Genital HPV Infection - CDC Fact Sheet [cited 2006 Jan 4]. Available from: www.cdc.gov/std/HPV/STDFact-HPV. htm
30. L. Markowitz Human Papillomavirus Vaccine Introduction and Overview of ACIP Presentations, Advisory Committee on Immunization Practices 2005 Atlanta, GA: June 30
31. D.M. Harper, E.L. Franco, C. Wheeler Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women a randomised controlled trial Lancet 364 2004 1757 1765
32. Skjeldestad FE, et al. Prophylactic quadrivalent human papillomavirus (HPV) (types 6, 11, 16, and 18) L1 virus-like particle (VLP) vaccine (Gardisil) reduces cervical intraepithelial neoplasia (CIN) 2/3 risk. Presented at: Infectious Disease Society of America 43rd Annual Meeting, October 7, 2005; San Francisco, Calif. Abstract LB-8a. Available at: http://www.idsociety.org/ template.cfm?section=program2&contentid=14108&template=/ contentmanagement/contentdisplay.cfm. Accessed January 26, 2006.
33. S. Goldie, M. Kohli, D. Grima Projected clinical benefits and cost-effectiveness of a Human Papillomavirus 16/18 vaccine J Natl Cancer Inst 96 2004 604 615